The table below shows ANAPTYSBIO, INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$25.56M
$76.32M
$22.26M
$27.77M
$30.02M
$10.97M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
-
$31.41M
$37.82M
$41.18M
$42.21M
$42.00M
SG&A
ANAB annual revenue (10-K history)
ANAPTYSBIO, INC reported annual revenue of $234.60M for fiscal year 2025. That is up 157.0% from $91.28M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $16.68M (FY 2016) to $234.60M. Figures come from the company's audited annual reports as filed with the SEC.